Your browser doesn't support javascript.
loading
ß2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.
Thanawala, Vaidehi J; Forkuo, Gloria S; Al-Sawalha, Nour; Azzegagh, Zoulikha; Nguyen, Long P; Eriksen, Jason L; Tuvim, Michael J; Lowder, Thomas W; Dickey, Burton F; Knoll, Brian J; Walker, Julia K L; Bond, Richard A.
Afiliación
  • Thanawala VJ; Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX 77204-5037, USA.
Am J Respir Cell Mol Biol ; 48(2): 220-9, 2013 Feb.
Article en En | MEDLINE | ID: mdl-23204390
ß(2)-Adrenoceptor (ß2AR) agonists are the most effective class of bronchodilators and a mainstay of asthma management. The first potent ß2AR agonist discovered and widely used in reversing the airway constriction associated with asthma exacerbation was the endogenous activator of the ß2AR, epinephrine. In this study, we demonstrate that activation of the ß2AR by epinephrine is paradoxically required for development of the asthma phenotype. In an antigen-driven model, mice sensitized and challenged with ovalbumin showed marked elevations in three cardinal features of the asthma phenotype: inflammatory cells in their bronchoalveolar lavage fluid, mucin over production, and airway hyperresponsiveness. However, genetic depletion of epinephrine using mice lacking the enzyme to synthesize epinephrine, phenylethanolamine N-methyltransferase, or mice that had undergone pharmacological sympathectomy with reserpine to deplete epinephrine, had complete attenuation of these three cardinal features of the asthma phenotype. Furthermore, administration of the long-acting ß2AR agonist, formoterol, a drug currently used in asthma treatment, to phenylethanolamine N-methyltransferase-null mice restored the asthma phenotype. We conclude that ß2AR agonist-induced activation is needed for pathogenesis of the asthma phenotype. These findings also rule out constitutive signaling by the ß2AR as sufficient to drive the asthma phenotype, and may help explain why chronic administration of ß2AR agonists, such as formoterol, have been associated with adverse outcomes in asthma. These data further support the hypothesis that chronic asthma management may be better served by treatment with certain "ß-blockers."
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Modelos Animales de Enfermedad / Etanolaminas / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Am J Respir Cell Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Modelos Animales de Enfermedad / Etanolaminas / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Am J Respir Cell Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos